Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

185.79
Delayed Data
As of Mar 05
 +3.26 / +1.79%
Today’s Change
136.37
Today|||52-Week Range
203.30
+0.41%
Year-to-Date

Today’s Trading

Previous close182.53
Today’s open182.81
Day’s range-- - --
Volume1,085,248
Average volume (3 months)1,258,162
Market cap$36.9B
Dividend yield--
Data as of 03/05/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)+13.57%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+46.49%
P/E ratio57.0
Price/Sales16.55
Price/Book11.00

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+6.91+5.76%
SHPGShire-1.58-0.66%
ZTSZoetis Inc+0.23+0.50%
PRGOPerrigo Company PLC+2.00+1.27%
Data as of 03/05/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$1.33
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO, Treasurer &
Director
Leonard Bell
Chief Operating Officer &
Director
David L. Hallal
Corporate headquarters
Cheshire, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account